この記事の翻訳を準備しています。それまでの間、英語の原文を表示します。
ビジネス · 2006/1/191 分で読めます
Able Laboratories, Inc.; Withdrawal of Approval of 43 Abbreviated New Drug Applications
ローカル自動翻訳 · 情報源の原言語
概要
The Food and Drug Administration (FDA) is withdrawing approval of 43 abbreviated new drug applications (ANDAs) held by Able Laboratories, Inc. (Able Labs), One Able Dr., Cranbury, NJ 08512. The drug products are no longer marketed, and Able Labs has requested that the approval of the applications be withdrawn.
情報源の原言語: Federal Register — Food and Drug Administration原文の発表を開く →